Canine longevity drug advances toward FDA approvalMarch 4, 2025The FDA’s Center for Veterinary Medicine has accepted the Reasonable Expectation of Effectiveness (RXE) for LOY-002. Learn more about what this ‘milestone’ means in the pursuit of an FDA conditional approval.
SPONSORED CONTENTOne dose protects for 12 months.One ProHeart® 12 (moxidectin) injection puts compliance in your control. + Get started
$45M additional funding bolsters development of canine longevity drugMarch 25, 2024The latest financing round brings the total funds raised for the first FDA-approved dog lifespan extension drug to $125M